MedPath

Famotidine

Famotidine Tablets USP

Approved
Approval ID

f55c8069-bfc1-4e37-b359-d3d1b10804ae

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 12, 2012

Manufacturers
FDA

Unit Dose Services

DUNS: 831995316

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Famotidine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50436-7371
Application NumberANDA075805
Product Classification
M
Marketing Category
C73584
G
Generic Name
Famotidine
Product Specifications
Route of AdministrationORAL
Effective DateNovember 12, 2012
FDA Product Classification

INGREDIENTS (9)

starch, cornInactive
Code: O8232NY3SJ
Classification: IACT
magnesium stearateInactive
Code: 70097M6I30
Classification: IACT
cellulose, microcrystallineInactive
Code: OP1R32D61U
Classification: IACT
polydextroseInactive
Code: VH2XOU12IE
Classification: IACT
talcInactive
Code: 7SEV7J4R1U
Classification: IACT
triacetinInactive
Code: XHX3C3X673
Classification: IACT
titanium dioxideInactive
Code: 15FIX9V2JP
Classification: IACT
FamotidineActive
Quantity: 20 mg in 1 1
Code: 5QZO15J2Z8
Classification: ACTIB
sodium starch glycolate type A potatoInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Famotidine - FDA Drug Approval Details